Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome

BACKGROUND: Hypereosinophilic syndrome (HES) is characterized by persistent elevated blood and/or tissue eosinophil levels and eosinophil-mediated organ damage. Presentation is highly heterogenous; patients may experience symptoms affecting multiple organ systems. OBJECTIVES: To assess the effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Roufosse, Florence, Butterfield, Joseph, Steinfeld, Jonathan, Bentley, Jane H., von Maltzahn, Robyn, Kwon, Namhee, Nelsen, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090544/
https://www.ncbi.nlm.nih.gov/pubmed/37064032
http://dx.doi.org/10.3389/fmed.2023.1035250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090544/
https://www.ncbi.nlm.nih.gov/pubmed/37064032
http://dx.doi.org/10.3389/fmed.2023.1035250

Ejemplares similares